| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 7,549,000 | 6,753,000 | 6,874,000 | 7,366,000 | | Cost of Revenue | 5,024,000 | 5,461,000 | 5,784,000 | 6,067,000 | | | Gross Profit | 2,525,000 | 1,292,000 | 1,090,000 | 1,299,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 431,000 | 424,000 | 465,000 | 508,000 | | Non Recurring | 672,000 |
-
|
-
|
-
| | Others | 626,000 | 556,000 | 488,000 | 713,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 796,000 | 312,000 | 137,000 | 78,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 631,000 | 312,000 | 137,000 | 78,000 | | Interest Expense | 97,000 | 95,000 | 77,000 | 67,000 | | Income Before Tax | 534,000 | 217,000 | 60,000 | 11,000 | | Income Tax Expense | 182,000 | 115,000 | 77,000 | 85,000 | | Minority Interest | (11,000) | (44,000) |
-
|
-
| | | | Net Income From Continuing Ops | 176,000 | 58,000 | (17,000) | (74,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 341,000 | 58,000 | (17,000) | (74,000) | | Preferred Stock And Other Adjustments |
-
| 42,000 | (42,000) |
-
| | | Net Income Applicable To Common Shares | $341,000 | $100,000 | ($59,000) | ($74,000) |
|
0.51% Nasdaq 
Income Statement
